** = Publikationen gelistet in SCI/SSCI/Pubmed
** Prinz, F; Jonas, K; Balihodzic, A; Klec, C; Reicher, A; Barth, DA; Riedl, J; Gerger, A; Kiesslich, T; Mayr, C; Rinner, B; Kargl, J; Pichler, M
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response.
RNA Biol. 2022; 19(1): 1305-1315.
Doi: 10.1080/15476286.2022.2152978
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Reicher, A; Harris, AL; Prinz, F; Kiesslich, T; Wei, M; Öllinger, R; Rad, R; Pichler, M; Kwong, LN
Generation of An Endogenous FGFR2-BICC1 Gene Fusion/58 Megabase Inversion Using Single-Plasmid CRISPR/Cas9 Editing in Biliary Cells.
Int J Mol Sci. 2020; 21(7): 2460
Doi: 10.3390/ijms21072460
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moik, F; Riedl, JM; Winder, T; Terbuch, A; Rossmann, CH; Szkandera, J; Bauernhofer, T; Kasparek, AK; Schaberl-Moser, R; Reicher, A; Prinz, F; Pichler, M; Stöger, H; Stotz, M; Gerger, A; Posch, F
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Sci Rep. 2019; 9(1):5548
Doi: 10.1038/s41598-019-42069-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG